InspireMD amends CEO and CFO employment agreements to enhance change-in-control severance

InspireMD, Inc.

CEO Marvin Slosman receives 24-month base salary severance plus 2x performance bonus on change-in-control termination.
CFO Craig Shore receives 12-month base salary severance plus 1x annual bonus on change-in-control termination.
Both executives get extended option exercise periods (CEO 2 years, CFO 1 year) and up to 24-month (CEO) or 12-month (CFO) benefit continuation.
Amendments effective April 1, 2024; triggered by termination within 3 months before or 12 months after a change in control.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.